Avalo Therapeutics, Inc. · NASDAQ:AVTX
FMR LLC reported a 10.80% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)
Event Jul 31, 2026 · Filed Aug 7, 2026
FMR LLC reported a 10.80% stake in Avalo Therapeutics, Inc., 5,737,966 shares, as a passive investor on Jul 31, 2026. Filed Aug 7, 2026 (Schedule 13G/A).
- Stake
- 10.80%
- Shares
- 5,737,966
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 10.80% | 5,737,966 |
| Abigail P. Johnson | 10.80% | 5,737,966 |
Source
Related
- Avalo Therapeutics, Inc.
- FMR LLC
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · FMR LLC · Jun 5, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G · FMR LLC · Mar 6, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026